Cristina Mascaró Selected Research

vafidemstat

1/2021	First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat.
1/2020	Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Mascaró Research Topics

Disease

2	Neoplasms (Cancer) 12/2021 - 01/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020 - 12/2018
2	Inflammation (Inflammations) 01/2020 - 09/2012
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Memory Disorders (Memory Loss) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Leukemia 12/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Carcinoma (Carcinomatosis) 09/2006

Drug/Important Bio-Agent (IBA)

3	Lysine (L-Lysine)FDA Link 12/2020 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2006
2	vafidemstatIBA 01/2021 - 01/2020
2	Histone DemethylasesIBA 12/2020 - 01/2015
1	Pargyline (Pargyline Hydrochloride)FDA Link 12/2021
1	AminesIBA 12/2021
1	Oxidoreductases (Dehydrogenase)IBA 12/2021
1	Phenelzine (Nardil)FDA Link 12/2021
1	Tranylcypromine (Parnate)FDA LinkGeneric 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2015
1	AntigensIBA 09/2012
1	CytokinesIBA 09/2012